Literature DB >> 31235553

IL-1β Induces the Rapid Secretion of the Antimicrobial Protein IL-26 from Th17 Cells.

David I Weiss1,2, Feiyang Ma2,3, Alexander A Merleev4, Emanual Maverakis4, Michel Gilliet5, Samuel J Balin1, Bryan D Bryson6, Maria Teresa Ochoa7, Matteo Pellegrini1,3, Barry R Bloom8, Robert L Modlin9,10.   

Abstract

Th17 cells play a critical role in the adaptive immune response against extracellular bacteria, and the possible mechanisms by which they can protect against infection are of particular interest. In this study, we describe, to our knowledge, a novel IL-1β dependent pathway for secretion of the antimicrobial peptide IL-26 from human Th17 cells that is independent of and more rapid than classical TCR activation. We find that IL-26 is secreted 3 hours after treating PBMCs with Mycobacterium leprae as compared with 48 hours for IFN-γ and IL-17A. IL-1β was required for microbial ligand induction of IL-26 and was sufficient to stimulate IL-26 release from Th17 cells. Only IL-1RI+ Th17 cells responded to IL-1β, inducing an NF-κB-regulated transcriptome. Finally, supernatants from IL-1β-treated memory T cells killed Escherichia coli in an IL-26-dependent manner. These results identify a mechanism by which human IL-1RI+ "antimicrobial Th17 cells" can be rapidly activated by IL-1β as part of the innate immune response to produce IL-26 to kill extracellular bacteria.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31235553      PMCID: PMC6684376          DOI: 10.4049/jimmunol.1900318

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  64 in total

1.  Antimicrobial peptides of multicellular organisms.

Authors:  Michael Zasloff
Journal:  Nature       Date:  2002-01-24       Impact factor: 49.962

Review 2.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

3.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

4.  Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells.

Authors:  Carol E Jones; Katie Chan
Journal:  Am J Respir Cell Mol Biol       Date:  2002-06       Impact factor: 6.914

5.  Modulation of bronchial epithelial cells by IL-17.

Authors:  M Kawaguchi; F Kokubu; H Kuga; S Matsukura; H Hoshino; K Ieki; T Imai; M Adachi; S K Huang
Journal:  J Allergy Clin Immunol       Date:  2001-11       Impact factor: 10.793

6.  Cutting edge: immune cells as sources and targets of the IL-10 family members?

Authors:  Kerstin Wolk; Stefanie Kunz; Khusru Asadullah; Robert Sabat
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

7.  Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2.

Authors:  Faruk Sheikh; Vitaliy V Baurin; Anita Lewis-Antes; Nital K Shah; Sergey V Smirnov; Shubha Anantha; Harold Dickensheets; Laure Dumoutier; Jean-Christophe Renauld; Alexander Zdanov; Raymond P Donnelly; Sergei V Kotenko
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

8.  The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains.

Authors:  Simon Hör; Heide Pirzer; Laure Dumoutier; Finn Bauer; Sabine Wittmann; Heinrich Sticht; Jean-Christophe Renauld; René de Waal Malefyt; Helmut Fickenscher
Journal:  J Biol Chem       Date:  2004-06-03       Impact factor: 5.157

9.  Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense.

Authors:  P Ye; F H Rodriguez; S Kanaly; K L Stocking; J Schurr; P Schwarzenberger; P Oliver; W Huang; P Zhang; J Zhang; J E Shellito; G J Bagby; S Nelson; K Charrier; J J Peschon; J K Kolls
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

10.  Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.

Authors:  P S Linsley; J L Greene; P Tan; J Bradshaw; J A Ledbetter; C Anasetti; N K Damle
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity.

Authors:  Giuseppe Palma; Gian Pio Sorice; Valentina Annamaria Genchi; Fiorella Giordano; Cristina Caccioppoli; Rossella D'Oria; Nicola Marrano; Giuseppina Biondi; Francesco Giorgino; Sebastio Perrini
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

Review 2.  The immunology of other mycobacteria: M. ulcerans, M. leprae.

Authors:  Katharina Röltgen; Gerd Pluschke; John Stewart Spencer; Patrick Joseph Brennan; Charlotte Avanzi
Journal:  Semin Immunopathol       Date:  2020-02-25       Impact factor: 9.623

3.  Single-cell analyses of Crohn's disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions.

Authors:  Natalia Jaeger; Ramya Gamini; Marina Cella; Jorge L Schettini; Mattia Bugatti; Shanrong Zhao; Charles V Rosadini; Ekaterina Esaulova; Blanda Di Luccia; Baylee Kinnett; William Vermi; Maxim N Artyomov; Thomas A Wynn; Ramnik J Xavier; Scott A Jelinsky; Marco Colonna
Journal:  Nat Commun       Date:  2021-03-26       Impact factor: 17.694

4.  Interleukin-26 Expression in Inflammatory Bowel Disease and Its Immunoregulatory Effects on Macrophages.

Authors:  Dongjuan Song; Lijie Lai; Juntao Lu; Jinlu Tong; Zhihua Ran
Journal:  Front Med (Lausanne)       Date:  2022-04-06

5.  Interleukin 26 Skews Macrophage Polarization Towards M1 Phenotype by Activating cJUN and the NF-κB Pathway.

Authors:  Yi-Hsuan Lin; Yi-Hsun Wang; Yi-Jen Peng; Feng-Cheng Liu; Gu-Jiun Lin; Shing-Hwa Huang; Huey-Kang Sytwu; Chia-Pi Cheng
Journal:  Cells       Date:  2020-04-10       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.